We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

The EM medical literature monitoring service enters into full effect

07 September 2015

On 1 September 2015, the European Medicines Agency (“EMA”) announced that its medical literature monitoring service, which is intended to identify suspected adverse reactions with medicinal products authorised in the European Union (“EU”) had entered into full effect.

To read more, click here.

The team

Loading data